Shifting of hepatitis A virus (HAV) epidemiology from a high towards an intermediate endemicity pattern and use of antiretroviral therapy increased the risk of HIV/HAV coinfection in developing countries. The aim of this study was to investigate the presence of HAV markers in a cohort of HIV-infected patients from 1988 to 2004. The presence of serum anti-HAV antibodies and HAV-RNA by real-time polymerase chain reaction was investigated in 581 patients. Total anti-HAV antibodies was found in 464/581 (79.8%) patients, however, achanging epidemiologic pattern of hepatitis A among HIV-infected patients from 1988 to 2004 was observed. Among patients susceptible to HAV (n = 117), 5 (4.2%) were co-infected with HAV, all of them had IgM anti-HAV antibodies and were serum HAV-RNA-positive. The high prevalence of anti-HAV antibodies in HIV-infected patients suggests that screening tests for anti-HAV antibodies should be performed before implementation of hepatitis A vaccination, especially in those patients from endemic countries.
Ministério da Saúde. Programa Nacional de DST e AIDS, 2006. See [http:www.aids.gov.br] (Accessed May 31, 2006)
2.
BicaI, McGovernB, DharR.Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis2001; 32: 492–7.
3.
RosenthalE, PoireeM, PradierC.Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study). AIDS2003; 17: 1803–9.
4.
JainMK, SkiestDJ, CloudJW, JainCL, BurnsD, BerggrenRE.Changes in mortality related to human immunodeficiency virus infection: comparative analysis of inpatient deaths in 1995 and in 1999-2000. Clin Infect Dis2003; 36: 1030–8.
5.
JaggyC, von OverbeckJ, LedergerberB.Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population. Lancet2003; 362: 877–8.
6.
QuintanaM, del AmoJ, BarrasaA.Progression of HIV infection and mortality by hepatitis C infection in patients with haemophilia over 20 years. Haemophilia2003; 9: 605–12.
7.
CotterSM, SansomS, LongT.Outbreak of hepatitis A among men who have sex with men: implications for hepatitis A vaccination strategies. J Infect Dis2003; 187: 1235–40.
8.
MazickA, HowitzM, RexS.Hepatitis A outbreak among MSM linked to casual sex and gay saunas in Copenhagen, Denmark. Euro Surveill2005; 10: 111–4.
9.
RidolfoAL, RusconiS, AntinoriS, BalottaC, GalliM.Persisting HIV-1 replication triggered by acute hepatitis A virus infection. Antivir Ther2000; 5: 15–7.
10.
Costa-MattioliM, AllavenaC, PoirierAS, BillaudelS, RaffiF, FerréV.Prolonged hepatitis A infection in an HIV-1 seropositive patient. J Med Virol2002; 68: 7–11.
11.
KaplanJE, MasurH, HolmesKK USPHS, Infectious Disease Society of America. Guidelines for preventing opportunistic infections among HIV-infected persons-2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep2002; 51: 1–52.
12.
WeissmanS, FeuchtC, MooreBA.Response to hepatitis A vaccine in HIV-positive patients. J Viral Hepat2006; 13: 81–6.
13.
JinF, PrestageGP, PellCM.Hepatitis A and B infection and vaccination in a cohort of homosexual men in Sydney. Sex Health.2004; 1: 227–37.
14.
LaurenceJC.Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus. Am J Med2005; 118: p75–83S.
15.
ShireNJ, WelgeJA, ShermanKE.Efficacy of inactivated hepatitis A vaccine in HIV-infected patients: a hierarchical Bayesian meta-analysis. Vaccine2006; 24: 272–9.
16.
De PaulaVS, Diniz-MendesL, VillarLM.Hepatitis A virus in environmental water samples from the Amazon Basin. Water Res2007; 41: 1169–76.
17.
VitralCL, GasparAM, SoutoFJ.Epidemiological pattern and mortality rates of hepatitis A in Brazil, 1980-2002 - a review. Mem Inst Oswaldo Cruz2006; 101: 119–27.
18.
SilvaPC, VitralCL, BarcellosC.Hepatitis A in the city of Rio de Janeiro, Brazil: epidemiological pattern and socio-environmental variables: cross-analysis of SINAN and population census data. Cad Saúde Pública2007; 23: 1553–64.
19.
BrunetA, GrabarS, BlancheP.Prevalence and risk factors of hepatitis A infection in an HIV-infected French population. Med Mal Infect2005; 35: 73–81.
20.
Tapia-ConyerR, SantosJI, CavalcantiAM.Hepatitis A in Latin America: a changing epidemiologic pattern. Am J Trop Med Hyg1999; 61: 825–9.
21.
TanakaJ.Hepatitis A shifting epidemiology in Latin America. Vaccine2000; 18: S57–60.
22.
GouveaAF, Moraes-PintoMI, MachadoDM.The prevalence of hepatitis A antibodies in HIV exposed and/or infected children and adolescents. J Pediatr (Rio J)2005; 81: 205–8.
23.
IdaS, TachikawaN, NakajimaA.Influence of human immunodeficiency virus type 1 infection on acute hepatitis A virus infection. Clin Infect Dis2002; 34: 379–85.
24.
NeilsenGA, BodsworthNJ, WattsN.Response to hepatitis A vaccination in human immunodeficiency virus-infected and uninfected homosexual men. J Infect Dis1997; 176: 1064–7.
25.
StewartT, CroftsN.An outbreak of hepatitis A among homosexual men in Melbourne. Med J Aust1993; 158: 519–21.
26.
ReintjesR, BosmanA, de ZwartO, StevensM, van der KnaapL, van den HoekK.Outbreak of hepatitis A in Rotterdam associated with visits to ‘darkrooms’ in gay bars. Commun Dis Public Health1999; 2: 43–6.
27.
BellA, NcubeF, HansellA.An outbreak of hepatitis A among young men associated with having sex in public venues. Commun Dis Public Health2001; 4: 163–70.
28.
BrookG.Prevention of viral hepatitis in HIV co-infection. J Hepatol2006; 44: S104–7.
29.
JacobsenKH, KoopmanJS.Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect2004; 132: 1005–22.
30.
AmadoLA, VillarLM, De PaulaVS.Detection of hepatitis A, B, and C virus-specific antibodies using oral fluid for epidemiological studies. Mem Inst Oswaldo Cruz2006; 101: 149–55.
31.
WortleyPM, FlemingPL.AIDS in women in the United States, recent trends. JAMA1997; 278: 911–6.
32.
FlemingPL, LanskyA, LeeLM.The epidemiology of HIV/AIDS in women in the Southern United States. Sex Transm Dis2006; 33: S32–8.
33.
Eyer-SilvaWA, SionFS, RibeiroLCP.Increasing proportion of women among patients with a recent diagnosis of HIV-1 infection (Abstract VSIMPAIDS-40). Fifth Brazilian Symposium on HIV/AIDS Research, Rio de Janeiro, 23-26 November 2003, Brazil
34.
ClemensR, SafaryA, HepburnA, RocheC, StanburyWJ, AndreFE.Clinical experience with an inactivated hepatitis A vaccine. J Infect Dis1995; 171: S44–9.
35.
CDC. The global HIV/AIDS pandemic, 2006. MMWR2006; 55: 841–4.
36.
SaabS, MartinP, YeeHFJr. A simple cost-decision analysis model comparing two strategies for hepatitis A vaccination. Am J Med2000; 109: 241–3.
